Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival early on in neoadjuvant treatment of breast cancer

摘要

BackgroundThe hypothesis of this study was that MRI-based radiomics has the ability to predict recurrence-free survival “early on” in breast cancer neoadjuvant chemotherapy.